Related Experiment Video
Updated: Jun 18, 2025
09:12
Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
Published on: June 14, 2024
861
[Development of dual-targeted CAR T-cell therapy]
1Department of Pediatrics, Graduate School of Medicine, Kyoto University.
Summary
Chimeric antigen receptor T-cell (CAR-T) therapy shows promise for blood cancers. New multi-targeted CAR-T cells, like CD19-CD20 and CD19-CD22, are being developed to overcome resistance caused by antigen loss.
Area of Science:
- Oncology
- Immunotherapy
- Cellular Therapy
Related Concept Videos
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
497
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
497